Diagnostic imaging of hepatocellular carcinoma at community hospitals and their tertiary referral center in the era of LI-RADS: a quality assessment study

被引:3
|
作者
Chan, Andrew [1 ]
Sertic, Madeleine [1 ]
Sammon, Jennifer [1 ,2 ]
Kim, Tae Kyoung [1 ,2 ]
Jang, Hyun-Jung [1 ,2 ]
Guimaraes, Luis [1 ,2 ]
O'Malley, Martin [1 ,2 ]
Khalili, Korosh [1 ,2 ,3 ]
机构
[1] Univ Toronto, Dept Med Imaging, Toronto, ON, Canada
[2] Univ Hlth Network, Womens Coll Hosp, Joint Dept Med Imaging, Sinai Hlth Syst, Toronto, ON, Canada
[3] Univ Hlth Network, Princess Margaret Canc Ctr, Joint Dept Med Imaging, 610 Univ Ave, Toronto, ON M5G 2M9, Canada
关键词
Hepatocellular carcinoma; Diagnosis; Quality; Liver; CT; MRI; LI-RADS; RELIABILITY; CRITERIA; VERSION; TUMOR;
D O I
10.1007/s00261-019-02237-3
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose To assess guideline compliance and quality of hepatocellular carcinoma, (HCC) diagnostic imaging within community hospitals (CH) and their Tertiary referral center (TRC) in a moderately high incidence region. Methods Initial diagnostic workup CT/MRI scans of 251 patients (122 CH, 112 TRC, 17 Non-TRC academic) with HCC over a 15-month period were assessed for Liver reporting and Data System (LI-RADS) guideline compliance. 269 scans (182 CT, 87 MRI) were qualitatively evaluated by 2 independent blinded radiologists for arterial timing, overall image quality, noise and sharpness, with quantification of interobserver variability. The contrast enhancement ratio (CER) for the largest HCC on each scan was calculated using pre- and post-contrast images. Results 103/104 (99%) of TRC and 44/78 (56%) of CH CTs adhered to LI-RADS imaging guidelines (P < 0.0001). Lack of delayed phase accounted for 32/34 (94%) of noncompliant CH CTs. Regarding MRI, 19/19 (100%) of TRC and 60/68 (88%) of CH scans were adherent (P = 0.12). For both modalities, overall image quality, noise and sharpness were rated significantly higher for TRC than CH. There was moderate interobserver agreement with intraclass correlation coefficient of 0.73, 0.70 and 0.63, respectively. Arterial-phase timing was rated adequate for CT in 75/104 TRC (72%) and 10/68 (14%) CH scans (P < 0.0001) and for MRI in 8/19 (42%) TRC and 23/68 (33%) CH scans (P = 0.17). The CER was significantly higher for TRC versus CH (2.9 vs. 1.9, P < 0.001) and MRI (0.9 vs. 0.7, P = 0.03). Conclusions Community hospital HCC diagnostic scans significantly lag in critical quality parameters of tumor enhancement, arterial phase timing, perceived image quality, and LI-RADS CT technique compliance compared to a TRC.
引用
收藏
页码:4028 / 4036
页数:9
相关论文
共 50 条
  • [21] Reply to "Standardizing diffusion-weighted imaging in LI-RADS for diagnosis of hepatocellular carcinoma"
    Cannella, Roberto
    Zins, Marc
    Brancatelli, Giuseppe
    EUROPEAN RADIOLOGY, 2025, 35 (02) : 698 - 699
  • [22] Quantitative radiomics and qualitative LI-RADS imaging descriptors for non-invasive assessment of β-catenin mutation status in hepatocellular carcinoma
    Arefan, Dooman
    D'Ardenne, Nicholas M.
    Iranpour, Negaur
    Catania, Roberta
    Yousef, Jacob
    Chupetlovska, Kalina
    Moghe, Akshata
    Sholosh, Biatta
    Thangasamy, Senthur
    Borhani, Amir A.
    Singhi, Aatur D.
    Monga, Satdarshan P.
    Furlan, Alessandro
    Wu, Shandong
    ABDOMINAL RADIOLOGY, 2024, 49 (07) : 2220 - 2230
  • [23] LI-RADS for MR Imaging Diagnosis of Hepatocellular Carcinoma: Performance of Major and Ancillary Features
    Cerny, Milena
    Bergeron, Catherine
    Billiard, Jean-Sebastien
    Murphy-Lavallee, Jessica
    Olivie, Damien
    Berube, Joshua
    Fan, Boyan
    Castel, Helene
    Turcotte, Simon
    Perreault, Pierre
    Chagnon, Miguel
    Tang, An
    RADIOLOGY, 2018, 288 (01) : 118 - 128
  • [24] US LI-RADS: ultrasound liver imaging reporting and data system for screening and surveillance of hepatocellular carcinoma
    Tara A. Morgan
    Katherine E. Maturen
    Nirvikar Dahiya
    Maryellen R. M. Sun
    Aya Kamaya
    Abdominal Radiology, 2018, 43 : 41 - 55
  • [25] Liver imaging reporting and data system (LI-RADS) v2018: Reliability and agreement for assessing hepatocellular carcinoma locoregional treatment response
    Abdelrahman, Ahmed S.
    Ekladious, Mena E. Y.
    Badran, Ethar M.
    Madkour, Sherihan S.
    DIAGNOSTIC AND INTERVENTIONAL IMAGING, 2022, 103 (11) : 524 - 534
  • [26] Liver Imaging Reporting and Data System (LI-RADS) Version 2018: Imaging of Hepatocellular Carcinoma in At-Risk Patients
    Chernyak, Victoria
    Fowler, Kathryn J.
    Kamaya, Aya
    Kielar, Ania Z.
    Elsayes, Khaled M.
    Bashir, Mustafa R.
    Kono, Yuko
    Do, Richard K.
    Mitchell, Donald G.
    Singal, Amit G.
    Tang, An
    Sirlin, Claude B.
    RADIOLOGY, 2018, 289 (03) : 816 - 830
  • [27] LI-RADS version 2018 for hepatocellular carcinoma &lt; 1.0 cm on gadoxetate disodium-enhanced magnetic resonance imaging
    Jang, Hyeon Ji
    Choi, Sang Hyun
    Choi, Se Jin
    Choi, Won-Mook
    Byun, Jae Ho
    Won, Hyung Jin
    Shin, Yong Moon
    EUROPEAN RADIOLOGY, 2023, 33 (08) : 5792 - 5800
  • [28] Update on Hepatocellular Carcinoma Imaging Features Associated With Histology, Subtype, and Prognosis Along With Changes to LI-RADS in 2024
    Klimkowski, Sergio P.
    Shi, Ann
    Altabbakh, Omar
    Szklaruk, Janio
    Shenoy-Bhangle, Anuradha S.
    Likhari, Gauruv S.
    Elsayes, Khaled M.
    SEMINARS IN ROENTGENOLOGY, 2025, 60 (01) : 6 - 18
  • [29] LI-RADS version 2018 for hepatocellular carcinoma < 1.0 cm on gadoxetate disodium–enhanced magnetic resonance imaging
    Hyeon Ji Jang
    Sang Hyun Choi
    Se Jin Choi
    Won-Mook Choi
    Jae Ho Byun
    Hyung Jin Won
    Yong Moon Shin
    European Radiology, 2023, 33 : 5792 - 5800
  • [30] Diagnostic performance of LI-RADS version 2018 in differentiating hepatocellular carcinoma from other hepatic malignancies in patients with hepatitis B virus infection
    Shao, Shuo
    Liang, Yingying
    Kuang, Sichi
    Chen, Jingbiao
    Shan, Qungang
    Yang, Hao
    Zhang, Yao
    Wang, Bin
    Fowler, Kathryn J.
    Wang, Jin
    Sirlin, Claude B.
    BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2020, 20 (03) : 401 - 410